Drug Shortage Report for PRALUENT

Last updated on 2021-11-09 History
Report ID 148536
Drug Identification Number 02453819
Brand name PRALUENT
Common or Proper name Praluent 75mg
Company Name SANOFI-AVENTIS CANADA INC
Market Status MARKETED
Active Ingredient(s) ALIROCUMAB
Strength(s) 75MG
Dosage form(s) SOLUTION
Route of administration SUBCUTANEOUS SUBCUTANEOUS
Packaging size 2
ATC code C10AX
ATC description LIPID MODIFYING AGENTS, PLAIN
Reason for shortage Other (Please describe in comments)
Anticipated start date
Actual start date 2021-10-29
Estimated end date 2021-11-08
Actual end date 2021-11-08
Shortage status Resolved
Updated date 2021-11-09
Company comments The availability date represents estimated availability at the main Sanofi warehouse. Availability dates at a customer’s usual distributor warehouse may vary. Pharmacies are invited to communicate with their preferred distributor to obtain the product availability date.
Health Canada comments
Tier 3 Status No
Company contact information email: CAINTERNET@sanofi.com Telephone: 1-800-265-7927

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v8 2021-11-09 English Compare
v7 2021-11-08 French Compare
v6 2021-11-08 English Compare
v5 2021-11-03 French Compare
v4 2021-11-03 English Compare
v3 2021-10-30 English Compare
v2 2021-10-29 French Compare
v1 2021-10-29 English Compare

Showing 1 to 8 of 8